This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. Although the state’s medical cannabis access program has been operational for some two decades, Maine officials only began tracking caregiver-related tax revenue in February of 2019.
Incidences of the vaping-related lung illness EVALI (e-cigarette or vaping product use-associated lung injury) are primarily concentrated to jurisdictions where adult-use cannabis consumption is prohibited, according to data published in the Journal of the American Medical Association (JAMA) Network Open.
” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. According to an August 2019 federal report , past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.
In 2019 the E-cigarette or Vaping-Use Associated Lung Injury (EVALI) outbreak was responsible for putting thousands of people in the hospital. An Analysis of Nationwide EVALI Data. Acknowledging this data, the study’s authors called for states to consider initiating home cultivation policies.
Sixty-six percent of US adults believe that “the use of marijuana should be made legal,” according to national survey data compiled by the Gallup. ” Never in modern history has there existed greater public support for ending the nation’s nearly century-long experiment with marijuana prohibition.
Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. AI-Powered search platform maximizes access to publications.
CannaTech Tel Aviv 2019 was an absolute sensation, and we are already looking to Cape Town for our next big event. This revolutionary storage device maintains optimal conditions for cannabis freshness and potency, and makes monitoring, tracking, dispensing, and procuring medical cannabis accessible to everyday patients.
Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Results highlight the need for expanded patient access to CBD products.”. CBD for hypertension.
“New Frontier Data was the first firm to identify and address the need for data in what is now a global cannabis market. We have spent over five years building the only cannabis Big Data technology platform that is able to ingest, scrub, process and report millions of data points.”
Date discovered : December 24, 2019. Date owners contacted : December 26, 2019. Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. As a consequence of this, the platform has access to a lot of private data related to dispensaries and their customers.
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.
1-2019: Cannabis Consumer Retail Engagement. New Frontier Data’s Consumer Insight Series: Cannabis Consumer Retail Engagement , explores consumer purchasing habits and what influences them. New Frontier Data has identified five forces changing the consumer landscape: Expanding legal access. Therapeutic efficacy.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.
Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Results highlight the need for expanded patient access to CBD products.”.
In 2019, California cannabis consumers continued to learn about and turn to cannabis to address their various needs. To provide a picture of California’s legal cannabis marketplace, we’ve aggregated our proprietary data to illustrate the behavior of over half a million cannabis consumers who purchased via the Eaze platform in 2019.
Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. 1, 2019, the day legal sales began, and Sept. The deadline for proposals is Friday, July 16. Between Dec.
Exclusive data collaboration between The Green Fund and Freshleaf Analytics. In April 2019, QLD amended their patient access process making it easier for doctors to write prescriptions. QLD is also well serviced with a variety of access clinics, which would have contributed to this relative increase. A 361% increase.
Editor’s Note: This following blog is an excerpt from an article that appeared in the March/April 2019 issue of Terpenes & Testing Magazine. Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. View the full article. . Publish to the Blockchain.
This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.
Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 billion, servicing nearly 340,000 active patients. . About RYAH Group, Inc.
From the systemic history of racism in the United States, African Americans exclusion from economic opportunities leads to maximizing profits for the White elite (Hirschman, 2019). Data were analyzed based on the central question, and three themes emerged. Theme 3 involved access to capital. Central Research Question.
The Legal Aid Society, an organization offering pro bono legal assistance to New York City’s most marginalized communities, is calling attention to new NYPD data showing that 94 percent of all cannabis arrests in 2020 targeted people of color. View original article.
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.
Data suggests that cannabis can be helpful for women with difficulties or dysfunction attaining orgasm. The four approvals mark the first expansion of the list of conditions that can be treated with medical cannabis since 2019. There may be a wide variety of causes for this syndrome.
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
Snohomish, WA — 7/24/2019 — Facebook, Cambridge Analytica, Google+… the list of data sharing scandals is long and filled with multi-million-dollar corporations. 420A3 decided to forego the “traditional revenue stream” that includes sharing/selling their data. How do these other companies get all this data? .
Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. These findings were corroborated in a 2019 study, where CBD: THC in combination with temozolomide increased the survival rate compared to placebo (83% vs. 56%).
They have data and reports in play and we presume have fairly healthy numbers in terms of B to B clients. October 10, 2019. said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. based New Frontier Data was founded in 2014 and has grown to over a 50-person team, with three offices in the United States and Europe.
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.
Texas’ consistent gains can, in large part, be attributed to its recent efforts to increase access to its program. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined. Hemp Study Shows Challenges of Regulation.
Google announced in May, 2019 that they had updated their policy section of the Google to ban apps “that facilitate the sale of marijuana or maijruan products, regardless of legality.” As co-founder Otha Smith said, “through data, we aim to empower not only cannabis consumers, but the entire industry.”.
Patients can also access CBD products without a prescription through local pharmacies. Our data confirm that PD patients have a high interest in treatment with medicinal cannabis but lacked knowledge about how to take it and especially the differences between the two main cannabinoids, THC and CBD,” said Buhmann.
MJ Biz writes…Only …… Approximately 333 patients accessed Denmark’s medical cannabis pilot scheme in the final quarter of 2019, according to recently released data from the … Read More.
Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Let’s find out. . Combat-Related PTSD is Slightly Different From PTSD .
16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 6, 2019, and Dec. 6, 2019, and Dec. The DHSS approved 23,000-plus patients and caregivers in program year 2019—before commercial sales began—with roughly 33% also approved to home cultivate.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.
Also missing: hard data about it. First published in 2017, and updated in 2019, the new 2021 Women & Minorities in the Cannabis Industry , is now available for download here. First published in 2017, and updated in 2019, the new 2021 Women & Minorities in the Cannabis Industry , is now available for download here.
2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” said Dr. Codi Peterson, PharmD, Chief Scientific Officer at the Cannigma.
Colorado marijuana dispensaries passed underage sales checks at a 95 percent rate in 2021, according to the MED, slightly down from 97 percent in 2020 and 2019. “It’s the availability and accessibility [of violation information], and putting it on par with what we’re doing in tobacco and alcohol.”
Backed by finance and banking industry veteran Jonathan Sandelman, Mercer Park completed its initial public offering and began trading on the NEO Exchange on May 13, 2019. Fully operational since June 2015, NEO puts investors first and provides access to trading across all Canadian-listed securities on a level playing field.
Report: US-based multistate marijuana operators poised to deploy big money in 2019. Report: US-based multistate marijuana operators poised to deploy big money in 2019. We are starting small, offering only our January 2019 Webinar on the 2018 Hemp Provisions of the Federal Farm Bill , until we can ensure that no additional bugs exist.
The prospects of the smaller domestic players will be significantly increased by transparent, secure and efficient sales channels and mechanisms granting them access to the global market. LIMITED TICKETS ARE AVAILABLE FOR CANNATECH CAPETOWN NOVEMBER 24-26, 2019. Saul Singer, CEO CMTREX. To register, please email info@cmtrex.com.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content